Philip K. Yachmetz, SVP, General Counsel at SAVIENT PHARMACEUTICALS INC (SVNT), sold 1,283 shares at $1.14 ($1K) on 2013-01-14, disclosed to the SEC on 2013-01-16.
Scheduled sale ($1k) by SVP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | BUY | 2011-09-16 | $29K | — | Filing → |
| SVNT | SELL | 2011-02-15 | $32K | — | Filing → |